Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: The ERECT Trial

Hiten D. Patel; Mohamad E. Allaf

doi:10.1016/j.euf.2018.01.002

Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: The ERECT Trial

Hiten D. Patel, Mohamad E. Allaf

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

Erythropoietin receptors have been localized to human penile tissue and periprostatic neurovascular bundles. ERECT is a placebo-controlled, phase 2, randomized trial assessing the effect of erythropoietin on recovery of erectile function for men undergoing radical prostatectomy for prostate cancer.

Original language	English (US)
Pages (from-to)	698-699
Number of pages	2
Journal	European Urology Focus
Volume	5
Issue number	4
DOIs	https://doi.org/10.1016/j.euf.2018.01.002
State	Published - Jul 2019

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.euf.2018.01.002

Cite this

@article{4a73852e11be420da7f0d5b9ab9dd4e8,

title = "Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: The ERECT Trial",

abstract = "Erythropoietin receptors have been localized to human penile tissue and periprostatic neurovascular bundles. ERECT is a placebo-controlled, phase 2, randomized trial assessing the effect of erythropoietin on recovery of erectile function for men undergoing radical prostatectomy for prostate cancer.",

author = "Patel, {Hiten D.} and Allaf, {Mohamad E.}",

note = "Publisher Copyright: {\textcopyright} 2018 European Association of Urology",

year = "2019",

month = jul,

doi = "10.1016/j.euf.2018.01.002",

language = "English (US)",

volume = "5",

pages = "698--699",

journal = "European Urology Focus",

issn = "2405-4569",

publisher = "Elsevier BV",

number = "4",

}

TY - JOUR

T1 - Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy

T2 - The ERECT Trial

AU - Patel, Hiten D.

AU - Allaf, Mohamad E.

PY - 2019/7

Y1 - 2019/7

N2 - Erythropoietin receptors have been localized to human penile tissue and periprostatic neurovascular bundles. ERECT is a placebo-controlled, phase 2, randomized trial assessing the effect of erythropoietin on recovery of erectile function for men undergoing radical prostatectomy for prostate cancer.

AB - Erythropoietin receptors have been localized to human penile tissue and periprostatic neurovascular bundles. ERECT is a placebo-controlled, phase 2, randomized trial assessing the effect of erythropoietin on recovery of erectile function for men undergoing radical prostatectomy for prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=85040619396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040619396&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2018.01.002

DO - 10.1016/j.euf.2018.01.002

M3 - Comment/debate

C2 - 29373284

AN - SCOPUS:85040619396

SN - 2405-4569

VL - 5

SP - 698

EP - 699

JO - European Urology Focus

JF - European Urology Focus

IS - 4

ER -

Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: The ERECT Trial

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this